# ZTALMY
> **NDA215904** · New Drug Application · Sponsor: IMMEDICA PHARMA · Approved 2022-03-18
## Drug
- **FDA Application Number:** NDA215904
- **Application type:** New Drug Application
- **Brand name:** ZTALMY
- **Generic name:** GANAXOLONE
- **Active ingredients:** GANAXOLONE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** IMMEDICA PHARMA
- **Manufacturer:** Immedica Pharma US Inc
- **First approval:** 2022-03-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215904)
---
*MORVS · CC0 1.0*